Dual GIP/GLP-1 receptor research compound studied for incretin signaling and metabolic response models.
Tirzepatide is a dual GIP/GLP-1 receptor research compound studied for incretin pathway signaling, food-intake regulation, glucose response, insulin-response models, and body-composition research.
Available strengths and ordering options are shown in the selector before checkout.
This catalog listing is for research-use purposes only. It is not medical guidance and does not imply treatment, prevention, diagnostic, or human-use claims.
